Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
Een sterke schakel: Evaluatie ZonMw-programma Goed Gebruik Geneesmiddelen
Schlingemann, Reinier
(Participant)
Ophthalmology
ACS - Atherosclerosis and Aortic Disease
ANS - Cellular & Molecular Mechanisms
Impact
:
Economic impacts
Description of impact
Out of the 1 billion Euro saved by 10 years of the GGG ZonMW programme, 720 million was generated by the three RCT's comparing lucentis and avastin initiated by RO Schlingemann
Category of impact
Economic impacts
X